New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients
Researchers from the RI-MUHC and the McGill Genome Centre examine differences in ICU patients who recovered or died from COVID-19 and identify candidate drugs to treat severe…
The dazzling potential of Ï㽶ÊÓƵ therapies
Billions of people around the world have now received a Moderna or BioNTech-Pfizer COVID-19 vaccine. Created with synthetically developed messenger ribonucleic acid (mÏ㽶ÊÓƵ) that…
Ï㽶ÊÓƵ joins Moderna in battle against global health threats
McGill is the first university in Canada to join the global platform that will accelerate the development of and expand the impact of mÏ㽶ÊÓƵ vaccines and medicines Ï㽶ÊÓƵ…
Similar to editing a film, mÏ㽶ÊÓƵ splicing allows cancer cells to change the narrative
Researchers identify mechanism that offers potential to new therapeutic avenues McGill researchers are part of a new study led by the University of California, San Francisco (UCSF)…
Researchers unlock mysteries of complex microÏ㽶ÊÓƵ oncogenes
New research led by McGill’s Goodman Cancer Research Centre improves our understanding of microÏ㽶ÊÓƵs MicroÏ㽶ÊÓƵs are tiny molecules of nucleic acid that control gene expression…